EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy of Double Membrane Filtration Immunoadsorption in Severe C1q-Binding Donor-Specific Antibody-Positive Acute Humoral Kidney Allograft Rejection: A Case Series

Martin Russwurm, Tanja Maier-Giebing, Birgit Kortus-Goetze, Philipp Russ, Hermann-Josef Groene, Joachim D Hoyer

Blood Purification · 2023

DOI: 10.1159/000528748 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood Purification, 2023. Verfasst von Martin Russwurm und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Centre for Internal Medicine, University Hospital Marburg, Marburg, Germany. Hauptthemen laut MEDLINE: Kidney Transplantation. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Acute antibody-mediated rejection (ABMR) is an important threat to renal allograft survival in the early transplant period and the major single cause of graft loss in the first postoperative year. Semi-selective immunoadsorption (IA) remains one of the commonly applied treatments in ABMR, reducing allo-reactive antibody load. Adding double filtration plasmapheresis (DFPP) to IA might enhance therapeutic efficacy by also addressing innate humoral effectors like complement factors.

Methods

Four patients with ABMR were treated with DFPP + IA. Clinical, histological, and immunological data and adverse events were retrospectively collected.

Results

Here we present four high-risk treatment-refractory ABMR cases with C1q-binding donor-specific antibodies and histology of humoral rejection under treatment with DFPP + IA. While the earlier cases (within the first year after transplantation) showed marked reduction in ABMR severity and improvement of kidney function, the later cases did not respond accordingly. Late ABMR patient 1 stabilized, whereas late ABMR patient 2 did not respond to treatment.

Conclusions

Our data support the consideration of DFPP + IA as a rescue treatment option in early, severe, high-risk ABMR cases in which other treatments failed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationHumansComplement C1qRetrospective StudiesKidneyAntibodiesAllograftsGraft RejectionGraft Survival

Stichwörter der Autor:innen

Acute antibody-mediated rejectionC1qDouble membrane filtrationImmunoadsorptionKidney transplantation

Substanzen

Complement C1qAntibodies

Autor:innen und Institutionen

  • Division of Nephrology, Centre for Internal Medicine, University Hospital Marburg, Marburg, Germany.
  • Institute of Pharmacology, Philipps-University, Marburg, Germany.
  • Medical Faculty, University of Heidelberg, Heidelberg, Germany.

Zitieren

APA

Russwurm, M., Maier-Giebing, T., Kortus-Goetze, B., Russ, P., Groene, H. J., & Hoyer, J. D. (2023). Efficacy of Double Membrane Filtration Immunoadsorption in Severe C1q-Binding Donor-Specific Antibody-Positive Acute Humoral Kidney Allograft Rejection: A Case Series. Blood Purification. https://doi.org/10.1159/000528748

Vancouver

Russwurm M, Maier-Giebing T, Kortus-Goetze B, Russ P, Groene HJ, Hoyer JD. Efficacy of Double Membrane Filtration Immunoadsorption in Severe C1q-Binding Donor-Specific Antibody-Positive Acute Humoral Kidney Allograft Rejection: A Case Series. Blood Purification. 2023. doi:10.1159/000528748

BibTeX
@article{Russwurm2023,
  author = {Russwurm, Martin and Maier-Giebing, Tanja and Kortus-Goetze, Birgit and Russ, Philipp and Groene, Hermann-Josef and Hoyer, Joachim D},
  title = {Efficacy of Double Membrane Filtration Immunoadsorption in Severe C1q-Binding Donor-Specific Antibody-Positive Acute Humoral Kidney Allograft Rejection: A Case Series},
  journal = {Blood Purification},
  year = {2023},
  doi = {10.1159/000528748}
}
Kostenlos starten →